Madeleine Grogg (#1575)
- $ 3 B
- Pharmaceuticals
- Switzerland
- F
- 0 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Madeleine Grogg is the widow of Peter Grogg, founder of Swiss biochemical company Bachem Holding AG. Peter Grogg, who died in 2025, started the business in 1971 and served as CEO until 2002, and chairman until 2012. Grogg and her two billionaire daughters all serve on the board of the family's asset management firm Ingro Finanz AG. Bachem AG develops and manufactures active pharmaceutical ingredients, including peptides, amino acid derivatives and other organic molecules. The family controls about 58% of Bachem as well as shares in Swiss electrical engineering company Burkhalter Holding and chemical maker Dottikon.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Madeleine Grogg’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Madeleine Grogg’s net worth journey over the years, highlighting key growth phases and financial milestones.
© Iconic Billionaires